GUANGZHOU, China, Feb. 23, 2026 /PRNewswire/ — Yatsen Holding Limited (“Yatsen” or the “Company”) (NYSE: YSG), a leading China-based beauty group, today announced that it will release its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on Monday, March 2, 2026, before the open of the U.S. markets.
The Company’s management will hold a conference call on Monday, March 2, 2026 at 7:30 A.M. U.S. Eastern Standard Time (8:30 P.M. Beijing/Hong Kong Time) to discuss the financial results. Listeners may access the call by dialing the following numbers:
|
United States (toll free): |
+1-888-346-8982 |
|
International: |
+1-412-902-4272 |
|
Mainland China (toll free): |
400-120-1203 |
|
Hong Kong (toll free): |
800-905-945 |
|
Hong Kong: |
+852-3018-4992 |
A live and archived webcast of the conference call will be available on the Company’s investor relations website at http://ir.yatsenglobal.com.
A replay of the conference call will be accessible by phone one hour after the conclusion of the live call at the following numbers, until March 9, 2026:
|
United States: |
+1-855-669-9658 |
|
International: |
+1-412-317-0088 |
|
Replay Access Code: |
2950633 |
About Yatsen Holding Limited
Yatsen Holding Limited (NYSE: YSG) is a leading China-based beauty group with the mission of creating an exciting new journey of beauty discovery for consumers around the world. Founded in 2016, the Company has launched and acquired numerous color cosmetics and skincare brands including Perfect Diary, Little Ondine, Pink Bear, Galénic, DR.WU (its mainland China business) and Eve Lom. The Company’s flagship brand, Perfect Diary, is one of the leading color cosmetics brands in China in terms of retail sales value. The Company primarily reaches and engages with customers directly both online and offline, with an expansive presence across all major e-commerce, social and content platforms in China.
For more information, please visit http://ir.yatsenglobal.com.
For investor and media inquiries, please contact:
Yatsen Holding Limited
Investor Relations
E-mail: ir@yatsenglobal.com

Đề xuất
MagnesiumFreeze Sciatic Nerve Claims Evaluated: Consumer Research Report Examines Magnesium Niacinamide Relief Topical Cream Ingredients, NAD+ Science, and Sciatic Nerve Support Discussions
AIM ImmunoTech Announces Closing of its Rights Offering
Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Curaechoice and Health Benefit Alliance Partner to Deliver No-Cost Healthcare to 161,000 Members Across 42 States
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Autoliv announces appointment of new CFO